NightHawk Biosciences (NHWK)

NightHawk Biosciences (NHWK) Stock Price & Analysis


NHWK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.50 - $1.90
Previous Close$0.55
Average Volume (3M)43.44K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$18.56M
Total Debt (Recent Filing)$11.24M
Price to Earnings (P/E)-0.3
Nov 13, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.01
Shares Outstanding26,081,890
10 Day Avg. Volume33,509
30 Day Avg. Volume43,443
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)0.41
Price to Sales (P/S)21.81
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was NightHawk Biosciences’s price range in the past 12 months?
NightHawk Biosciences lowest stock price was $0.50 and its highest was $1.90 in the past 12 months.
    What is NightHawk Biosciences’s market cap?
    Currently, no data Available
    When is NightHawk Biosciences’s upcoming earnings report date?
    NightHawk Biosciences’s upcoming earnings report date is Nov 13, 2023 which is in 50 days.
      How were NightHawk Biosciences’s earnings last quarter?
      NightHawk Biosciences released its earnings results on Aug 14, 2023. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.53.
        Is NightHawk Biosciences overvalued?
        According to Wall Street analysts NightHawk Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does NightHawk Biosciences pay dividends?
          NightHawk Biosciences does not currently pay dividends.
          What is NightHawk Biosciences’s EPS estimate?
          NightHawk Biosciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does NightHawk Biosciences have?
          NightHawk Biosciences has 26,081,890 shares outstanding.
            What happened to NightHawk Biosciences’s price movement after its last earnings report?
            NightHawk Biosciences reported an EPS of -$0.53 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of NightHawk Biosciences?
              Currently, no hedge funds are holding shares in NHWK


              NightHawk Biosciences Stock Smart Score

              Not Ranked
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              NightHawk Biosciences

              Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.


              Top 5 ETFs holding NHWK

              Market Value
              Smart Score
              Vanguard Total Stock Market ETF
              iShares Core S&P Total U.S. Stock Market ETF
              Up to five ETFs with an Outperform Smart Score that hold NHWK. The ETFs are listed according to market value of NHWK within the ETF

              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Vascular Biogenics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis